CClinicalTrials.gg
CompletedNCT04371614PTSC-RCTUpdated Oct 5, 2022

PTSC: Improving Hypertension Control Among Poor Midlife African American Women

An interventional study of Prime Time Sister Circle in Uncontrolled Hypertension, BMI and Stress, sponsored by Johns Hopkins Bloomberg School of Public Health. Completed at 1 site in United States. Open to female participants aged 40 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-05.

Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 years 9 months after the study started (first participant enrolled Jul 2016, registered Apr 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
359
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
Female
01

Study summary

African American women are more likely to suffer higher rates of uncontrolled hypertension than non-Hispanic white women. Prime Time Sister Circles® (PTSC) empowers women to proactively manage their blood pressure by promoting the effective use of preventive health care; encouraging self monitoring of blood pressure, and teaching strategies for managing stress, increasing physical activity, and improving nutrition. The 12-week community-based, holistic lifestyle intervention aims to improve blood pressure control by improving health knowledge, health efficacy, and health behaviors. PTSC potentially reduces health care costs through prevention, earlier detection, and improved management of hypertension through a culturally tailored program addressing specific barriers experienced by midlife and late life African American women.

This 5-year study is a collaboration between The Johns Hopkins Center for Health Disparities Solutions (HCHDS), The Gaston \& Porter Health Improvement Center, Inc. (GPHIC), and the American Institutes for Research (AIR). The investigators seek to determine the impact and cost-effectiveness of the PTSC intervention among low-income African American women with uncontrolled hypertension. To do this, the investigators will randomly assign 600 women between the ages of 40 and 75 who receive their care from an federally qualified health center (FQHC) to either PTSC (n=300) or a comparison group (n=300) who will receive the PTSC intervention after they have been observed for 15 month. Using data from in person surveys and clinical measures conducted during in-person data collection meetings, the investigative team will determine if PTSC help low-income African American women effectively manage their blood pressure.

Read the detailed description

African American women suffer significantly higher rates of hypertension than non-Hispanic white women. Forty-six to fifty percent of African American women have hypertension, compared with 31 percent of White women making it a major contributor to disparities in cardiovascular morbidity and mortality in this population from higher rates of complications, i.e., ischemic heart disease, stroke, and end-stage renal disease. Despite these statistics, African American women are less often aware of their diagnosis, less likely to have their blood pressure controlled, and less likely to be treated. From a societal perspective, high blood pressure was estimated to cost the United States approximately $93.5 billion in health care services, medications, and missed work days in 2010.

Public and private health plans, employers, and health care providers are seeking cost-effective approaches to preventing and improving management of uncontrolled hypertension (140/90 and above). Prime Time Sister Circles® (PTSC) empowers women to proactively manage their health by promoting the effective use of preventive health care; providing screening and monitoring of blood pressure and weight, and teaching strategies for managing stress, increasing physical activity, and improving nutrition. The 13-week community-based, holistic lifestyle intervention aims to improve blood pressure control and reduce health care costs through prevention, earlier detection, and improved management of hypertension through a culturally tailored program addressing specific risk factors and barriers experienced by mid to late life African American women.

The primary objective of this research project is to determine the impact and cost-effectiveness of the PTSC intervention among low-income African American women with uncontrolled hypertension. This 5-year study is a collaboration between The Johns Hopkins Center for Health Disparities Solutions (HCHDS), The Gaston \& Porter Health Improvement Center, Inc. (GPHIC), and the American Institutes for Research (AIR). Study participants will be recruited from FQHCs in Washington, DC and Baltimore, MD. These FQHCs were chosen because they are medical homes to a large number of low income midlife African American women who have hypertension. The sample, 480 African American women between the ages of 40 and 75 who receive their primary care from a FQHC, will be randomly assigned to receive the PTSC intervention (n=240) or usual care for a FQHC (n=240). Data on blood pressure, health status, health behaviors, and health care utilization will be collected through participant surveys and administrative records from the FQHCs. Blood pressure measurements and surveys will be collected at baseline, 13 weeks (end of program), 9 months (6 months after the end of the program), and 15 months (a year after the end of the program). Administrative records to track health services use and costs will be collected on an ongoing basis over the same time period. These data will be used to address the following specific aims:

Aim 1. Estimate the effectiveness of PTSC compared with usual care on blood pressure control among hypertensive, low-income, mid-to-late life African American women.

Hypothesis 1.1 Patients randomized to PTSC will have better controlled blood pressure than patients who receive usual care at the end of the intervention (13 weeks) and up to one year post intervention (15 months).

Aim 2. Estimate the effectiveness of PTSC on health knowledge, health self-efficacy, and health behaviors that contribute to risks associated with hypertension.

Hypothesis 2.1 Patients randomized to PTSC will demonstrate a greater increase in knowledge of the causes and consequences of high blood pressure than patients receiving usual care.

Hypothesis 2.2 Patients randomized to PTSC will demonstrate a greater increase in health-related self-efficacy than patients receiving usual care.

Hypothesis 2.3 Patients randomized to PTSC will practice more adaptive stress management techniques, increase their level of physical activity, and improve their diets more than patients receiving usual care.

Hypothesis 2.4 Patients randomized to PTSC will monitor their own blood pressure more regularly than patients receiving usual care.

Hypothesis 2.5: Patients randomized to PTSC will be more compliant with taking prescribed hypertension medications than patients receiving usual care.

Aim 3. Test whether there is a cost offset of PTSC for society. Hypothesis 3.1 Patients randomized to PTSC will have fewer unnecessary hospitalizations and emergency rooms visits for cardiovascular related problems than patients receiving usual care.

Hypothesis 3.2 Patients randomized to PTSC will have fewer hospital admissions for cardiovascular related problems than patients receiving usual care.

Hypothesis 3.3 The costs of providing PTSC will be offset by reductions in healthcare costs associated with health improvements for patients randomized to PTSC compared to patients receiving usual care.

FQHCs and other safety net providers are challenged to effectively manage the hypertension of their midlife African American female patients. PTSC may be a viable low-cost, community-based intervention that physicians can use as a resource for their patients to support necessary lifestyle changes and improve their health.

02

Conditions studied

  • Uncontrolled Hypertension
  • BMI
  • Stress
  • Medication Adherence

Browse trials for

Keywords

  • Hypertension
  • African American women
  • Lifestyle Modification
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 359 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 364 studies on the registry; 41 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • diagnosed with hypertension (401)
  • had a visit to the FQHC within the prior 24 months
  • had an elevated blood pressure (140/90 or above) at their last visit
  • able to speak English

Exclusion criteria

Exclusion Criteria:

  • diagnosed with psychotic disorders (295.42, 295.90)
  • diagnosed with dementia (290)
  • diagnosed with other nutritional deficiencies (269.9)
  • diagnosed with congestive heart failure (428)
  • diagnosed with blindness (369.3)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
359 participants (actual)

Study arms

  • Active comparator
    Prime Time Sister Circle Intervention

    The women in this arm participate in a Prime Time Sister Circle (PTSC). The PTSC is a multi-faceted, facilitated, curriculum- and community-based, intensive, support group intervention with 25-30 mid-life African American women per group. PTSC addresses three key modifiable health risk factors for chronic disease: unmanaged stress, physical inactivity, and unhealthy nutritional choices. It also addresses additional risk factors that contribute to unhealthy lifestyles: lack of knowledge or misinformation about major illnesses-cardiovascular disease (CVD), hypertension, diabetes, cancer, stress and depression-and the failure of African American women to prioritize their health and take proactive steps to manage their health and health outcomes. PTSC gives African American women the information, motivation, tools, skills, and consultative support they need to improve and maintain their health.

    Behavioral: Prime Time Sister Circle

  • No intervention
    Usual Care

    The women in the arm do not receive the intervention but provide data at baseline, 3 months, 9 months and 15 months.

Interventions

  • BehavioralPrime Time Sister Circle

    The PTSC is a multi-faceted, facilitated, curriculum- and community-based, intensive, support group intervention with 25-30 mid-life African American women per group.

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Systolic and Diastolic Blood Pressure

    Time frame: Baseline

  2. Blood Pressure

    Systolic and Diastolic Blood Pressure

    Time frame: 3 months

  3. Blood Pressure

    Systolic and Diastolic Blood Pressure

    Time frame: 9 months

  4. Blood Pressure

    Systolic and Diastolic Blood Pressure

    Time frame: 15 months

  5. Body Mass Index

    Calculation based on height and weight

    Time frame: Baseline

  6. Body Mass Index

    Calculation based on height and weight

    Time frame: 3 months

  7. Body Mass Index

    Calculation based on height and weight

    Time frame: 9 months

  8. Body Mass Index

    Calculation based on height and weight

    Time frame: 15 months

  9. Waist Circumference

    Measured in centimeters

    Time frame: Baseline

  10. Waist Circumference

    Measured in centimeters

    Time frame: 3 months

  11. Waist Circumference

    Measured in centimeters

    Time frame: 9 months

  12. Waist Circumference

    Measured in centimeters

    Time frame: 15 months

Secondary outcomes

  1. Stress

    Perceived Stress Scale Respondents are asked to rate their current stress level on a scale from 1 to 7, where 1 means "not at all stressed," and 7 means "extremely stressed,"

    Time frame: Baseline

  2. Stress

    Perceived Stress Scale Respondents are asked to rate their current stress level on a scale from 1 to 7, where 1 means "not at all stressed," and 7 means "extremely stressed,"

    Time frame: 3 months

  3. Stress

    Perceived Stress Scale Respondents are asked to rate their current stress level on a scale from 1 to 7, where 1 means "not at all stressed," and 7 means "extremely stressed,"

    Time frame: 9 months

  4. Stress

    Perceived Stress Scale Respondents are asked to rate their current stress level on a scale from 1 to 7, where 1 means "not at all stressed," and 7 means "extremely stressed,"

    Time frame: 15 months

  5. Medication Adherence

    Hill-Bone High Blood Pressure Compliance Scale This is a scale based on 14 questions where respondents answer 1. Not at all 2. Some of the time 3. Most of the time 4. All of the time The items are additive. The minimum score is 14 indicating most compliance and the maximum is 56 indicating least compliance.

    Time frame: Baseline

  6. Medication Adherence

    Hill-Bone High Blood Pressure Compliance Scale This is a scale based on 14 questions where respondents answer 1. Not at all 2. Some of the time 3. Most of the time 4. All of the time The items are additive. The minimum score is 14 indicating most compliance and the maximum is 56 indicating least compliance.

    Time frame: 3 months

  7. Medication Adherence

    Hill-Bone High Blood Pressure Compliance Scale This is a scale based on 14 questions where respondents answer 1. Not at all 2. Some of the time 3. Most of the time 4. All of the time The items are additive. The minimum score is 14 indicating most compliance and the maximum is 56 indicating least compliance.

    Time frame: 9 months

  8. Medication Adherence

    Hill-Bone High Blood Pressure Compliance Scale This is a scale based on 14 questions where respondents answer 1. Not at all 2. Some of the time 3. Most of the time 4. All of the time The items are additive. The minimum score is 14 indicating most compliance and the maximum is 56 indicating least compliance.

    Time frame: 15 months

  9. Hypertension Knowledge

    COUNSELING AFRICAN AMERICANS TO CONTROL HYPERTENSION (CAATCH) This is a 17 item scale where respondents answer True or False to questions about hypertension. The scale has a minimum value of 0 which indicates the respondent is not very knowledgeable about hypertension to 17 which indicates the respondent is very knowledgeable about hypertension.

    Time frame: Baseline

  10. Hypertension Knowledge

    COUNSELING AFRICAN AMERICANS TO CONTROL HYPERTENSION (CAATCH) This is a 17 item scale where respondents answer True or False to questions about hypertension. The scale has a minimum value of 0 which indicates the respondent is not very knowledgeable about hypertension to 17 which indicates the respondent is very knowledgeable about hypertension.

    Time frame: 3 months

  11. Hypertension Knowledge

    COUNSELING AFRICAN AMERICANS TO CONTROL HYPERTENSION (CAATCH) This is a 17 item scale where respondents answer True or False to questions about hypertension. The scale has a minimum value of 0 which indicates the respondent is not very knowledgeable about hypertension to 17 which indicates the respondent is very knowledgeable about hypertension.

    Time frame: 9 months

  12. Hypertension Knowledge

    COUNSELING AFRICAN AMERICANS TO CONTROL HYPERTENSION (CAATCH) This is a 17 item scale where respondents answer True or False to questions about hypertension. The scale has a minimum value of 0 which indicates the respondent is not very knowledgeable about hypertension to 17 which indicates the respondent is very knowledgeable about hypertension.

    Time frame: 15 months

  13. Functional Status

    EuroQol 5 This is a 5 item scale where respondent are asked whether have problems along five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Respondent rate each item based on five point scale: (1) no, (2) slight, (3) some, (4) moderate, or (5) extreme. The scale is scored based on a country and population specific valuation that is proprietary. Each dimension make up a digit in a five digit code: 1,1,1,1,1 indicate most healthy state while 5,5,5,5,5 indicates the most unhealthy state.

    Time frame: Baseline

  14. Functional Status

    EuroQol 5 This is a 5 item scale where respondent are asked whether have problems along five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Respondent rate each item based on five point scale: (1) no, (2) slight, (3) some, (4) moderate, or (5) extreme. The scale is scored based on a country and population specific valuation that is proprietary. Each dimension make up a digit in a five digit code: 1,1,1,1,1 indicate most healthy state while 5,5,5,5,5 indicates the most unhealthy state.

    Time frame: 15 months

07

Study locations

1 site
  • Baltimore Medical System
    Baltimore, Maryland 21213, United States
08

References and documents

Publications

  • Ibe CA, Haywood DR, Creighton C, Cao Y, Gabriel A, Zare H, Jones W, Yang M, Balamani M, Gaston M, Porter G, Woods DL, Gaskin DJ. Study protocol of a randomized controlled trial evaluating the Prime Time Sister Circles (PTSC) program's impact on hypertension among midlife African American women. BMC Public Health. 2021 Mar 29;21(1):610. doi: 10.1186/s12889-021-10459-8. PubMed 33781228 ↗
  • Gabriel A, Zare H, Jones W, Yang M, Ibe CA, Cao Y, Balamani M, Gaston M, Porter G, Woods DL, Gaskin DJ. Evaluating Depressive Symptoms Among Low-Socioeconomic-Status African American Women Aged 40 to 75 Years With Uncontrolled Hypertension: A Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry. 2021 Apr 1;78(4):426-432. doi: 10.1001/jamapsychiatry.2020.4622. PubMed 33566072 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04371614
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
American Institutes for Research, The Gaston & Porter Health Improvement Center, Inc.
Responsible party
Sponsor
First posted
May 1, 2020
Start date
Jul 14, 2016
Primary completion
Mar 19, 2019
Completion
Jul 31, 2020
Last update
Oct 5, 2022

Study contacts

Darrell J Gaskin, PhD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion